This merits speculation that through binding to the RAGE receptor, HMGB1 may help cervical cells evade immunosuppression, and accelerate the process of “HPV infection to CIN to cervical cancer” by influencing T cell-mediated immunity. Here, HMGB1 is linked to cervical cancer.